Cerba Research, Biokortex forge patient-data partnership
The collaboration will leverage patients’ biological and medical data to streamline patient identification and recruitment efforts in clinical research.
The collaboration will leverage patients’ biological and medical data to streamline patient identification and recruitment efforts in clinical research.
The pharma firm is partnering with the decentralized research organization on a Phase III trial testing a long-acting antibody combination treatment.
The US Food and Drug Administration (FDA) has issued guidance for companies developing vaccines, diagnostics and therapeutics against new variants of SARS-CoV-2.